TCIM
IRWD icon

TIAA CREF Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

TIAA CREF Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$5.6M Buy
494,257
+170,222
+53% +$1.9M ﹤0.01% 1364
2018
Q4 		$2.81M Sell
324,035
-8,556
-3% -$98.2K ﹤0.01% 1745
2018
Q3 		$5.14M Sell
332,591
-32,347
-9% -$511K ﹤0.01% 1545
2018
Q2 		$5.84M Sell
364,938
-119,619
-25% -$1.77M ﹤0.01% 1492
2018
Q1 		$6.26M Buy
484,557
+91,255
+23% +$1.14M ﹤0.01% 1421
2017
Q4 		$4.94M Sell
393,302
-25,532
-6% -$333K ﹤0.01% 1603
2017
Q3 		$5.53M Sell
418,834
-13,226
-3% -$182K ﹤0.01% 1557
2017
Q2 		$6.83M Buy
432,060
+11,468
+3% +$167K ﹤0.01% 1381
2017
Q1 		$6.01M Sell
420,592
-21,639
-5% -$296K ﹤0.01% 1473
2016
Q4 		$5.66M Sell
442,231
-28,372
-6% -$358K ﹤0.01% 1522
2016
Q3 		$6.26K Sell
470,603
-6,149
-1% -$71.9K ﹤0.01% 1448
2016
Q2 		$5.22M Sell
476,752
-2,619
-0.5% -$25.6K ﹤0.01% 1505
2016
Q1 		$4.39M Sell
479,371
-6,765
-1% -$55.8K ﹤0.01% 1589
2015
Q4 		$4.72M Sell
486,136
-6,252
-1% -$60.4K ﹤0.01% 1596
2015
Q3 		$4.3M Sell
492,388
-35,282
-7% -$329K ﹤0.01% 1637
2015
Q2 		$5.33M Buy
527,670
+18,999
+4% +$221K ﹤0.01% 1635
2015
Q1 		$6.82M Sell
508,671
-12,979
-2% -$170K ﹤0.01% 1412
2014
Q4 		$6.69M Sell
521,650
-28,884
-5% -$331K ﹤0.01% 1418
2014
Q3 		$5.97M Sell
550,534
-9,544
-2% -$109K ﹤0.01% 1477
2014
Q2 		$7.19M Buy
560,078
+70,465
+14% +$766K 0.01% 1414
2014
Q1 		$5.05M Buy
489,613
+27,140
+6% +$305K ﹤0.01% 1603
2013
Q4 		$4.5M Buy
462,473
+15,813
+4% +$142K ﹤0.01% 1711
2013
Q3 		$4.43M Sell
446,660
-15,505
-3% -$152K ﹤0.01% 1663
2013
Q2 		$3.85M Buy
+462,165
New +$5.6M ﹤0.01% 1718

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

TIAA CREF Investment Management's IRWD Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Ironwood Pharmaceuticals (IRWD) stake by 53% in Q1 2019, buying an estimated $1.9M and bringing the position to 494,257 shares worth $5.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1364.

TIAA CREF Investment Management first reported a position in IRWD in Q2 2013 and has held it in 24 quarters since. The position peaked at $7.19M in Q2 2014. 156 funds tracked by Wall St. Rank hold IRWD as of Q1 2019.

  • TIAA CREF Investment Management held 494,257 shares of Ironwood Pharmaceuticals worth $5.6M as of Q1 2019.
  • TIAA CREF Investment Management bought 170,222 Ironwood Pharmaceuticals shares in Q1 2019, an estimated $1.9M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1364 holding.
  • TIAA CREF Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Ironwood Pharmaceuticals position peaked at $7.19M in Q2 2014.
  • 156 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.